Thermo Fisher Scientific, Pfizer Partner to Bring NGS-Based Cancer Tests to Underserved Markets
The collaboration will expand NGS-based tests for lung and breast cancers in more than 30 countries, where advanced genomic testing has been limited.
Nucleix Bladder EpiCheck Cancer Liquid Biopsy Test Gets FDA 510(k) Clearance
The DNA methylation-based urine PCR test is cleared for monitoring patients diagnosed with non-muscle invasive bladder cancer for recurrence.
Smartphone-Based Kidney Test Maker Healthy.io Raises $50M in Series D Round
The firm said the financing will support US expansion of its at-home urine-based Minuteful Kidney test for chronic kidney disease.
ChromaCode, MedGenome Ink India, Middle East Distribution Deal
The deal between the US-based firms will expand availability of ChromaCode's PCR platform and a non-small cell lung cancer assay on the platform.
Angle, BioView Partner to Develop Quantitative HER2 Assay Using Circulating Tumor Cells
The companies said recent developments in HER2-targeted therapies have created new commercial opportunities for a blood-based test.